Blueprint Genetics Laboratory located in Finland is a CLIA-certified (#99D2092375) laboratory and accredited by the College of American Pathologists (CAP #9257331) and by FINAS Finnish Accreditation Service, laboratory no. T292, accreditation requirement SFS-EN ISO 15189:2013. Detailed information about the scope is available on the FINAS website.
Blueprint Genetics Laboratory located in Seattle, WA is a CLIA-certified (#50D2140410) laboratory and accredited by the College of American Pathologists (CAP #8263129).
We offer genetic testing globally covering North and South America, Europe, Australia and the Middle East.
All Blueprint Genetics panel tests are CE-marked, general IVD devices.
Blueprint Genetics Finland licensure:
Name |
Nr. |
Valid until |
CAP accreditation |
#9257331 | Apr 22, 2022 |
ISO 15189 Accredited by FINAS |
No. T292 | Feb 2, 2024 |
CLIA – Clinical Laboratory Improvement Amendments |
#99D2092375 | Apr 20, 2023 |
State of California License |
#CDS00800637 | Apr 30, 2022 |
State of Maryland License |
#2409 | Non-expiring |
State of Pennsylvania License |
#34897 | Aug 15, 2022 |
State of Rhode Island License |
#LCO01312 | Dec 30, 2022 |
Blueprint Genetics Seattle, WA licensure:
Name |
Nr. |
Valid until |
CAP accreditation |
#8263129 | Dec 3, 2022 |
MTS / CLIA – Clinical Laboratory Improvement Amendments |
#50D2140410 | Jun 30, 2023 |
State of California License |
#CDS00800903 | Apr 10, 2022 |
State of Maryland License |
#3156 | Non-expiring |
State of Pennsylvania License |
#37899 | Aug 15, 2022 |
State of Rhode Island License |
#LCO01345 | Dec 30, 2021 |
Please see more information about our quality control and accreditation through the following link:
Please contact our Quality Management Team with any questions regarding laboratory quality and regulatory compliance (eg, certifications) at quality@blueprintgenetics.com.